TrialScope

@TrialScope

Through best-in-class software and expert services we empower clinical trial sponsors to optimize disclosure management and maximize trial data transparency.

Greater New York City Area
Vrijeme pridruživanja: svibanj 2014.

Tweetovi

Blokirali ste korisnika/cu @TrialScope

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @TrialScope

  1. prije 15 sati

    sponsors can put and into practice with plain language summaries. This PLS webinar features experts from Jazz Pharmaceuticals, ClaritiDox and TrialScope. Register today:

    Poništi
  2. prije 16 sati

    As this article indicates, global regulations are complex. Each country's registry has different timelines and data requirements. Plus, there no single standard on how data is captured and reported. At TrialScope, we help manage it all.

    Poništi
  3. prije 17 sati

    The first Cancer Clinical Trials survey shows that most patients are interested in taking part in clinical trials. However, 43% of all patients surveyed reported that their medical teams never discussed with them.

    Poništi
  4. 4. velj

    It's Patient Recognition Week, and we'd like to thank all the patients who participate in research.

    Poništi
  5. 3. velj

    Global recruitment rates have been on the rise over the past seven years, thanks to new techniques designed to make patient participation easier, but the benefits have not translated to patient retention, according to a new study.

    Poništi
  6. 30. sij

    Join Jazz Pharmaceuticals, ClaritiDox and TrialScope for an information-packed webinar on plain language summaries. Hear how to set up a successful PLS program, best practices, trends and more.

    Poništi
  7. 28. sij

    Check out the first in an 8-part series on transparency policies, by Thomas Wicks, Chief Strategy officer.

    Poništi
  8. 28. sij

    Mike Wenger, Vice President of Patient Engagement, looks into his crystal ball and makes a few predictions on where healthcare tech is headed in 2020. What does he see? For starters, API adoption.

    Poništi
  9. 27. sij

    With a focus on collaboration, this webinar reveals how EMD Serono, TrialScope and CISCRP worked together to launch the EMD Serono website. Now available on demand:

    Poništi
  10. 24. sij

    Patients don't participate in due to lack of education/awareness, access & financial issues. The Leukemia & Lymphoma Society Clinical Trial Support Center, in conjunction with the American Hematology Society, seeks to change that.

    Poništi
  11. 23. sij

    Mike Wenger, TrialScope VP of Patient Engagement, discusses access to and at the CBI conference in Miami.

    Poništi
  12. 23. sij

    Thomas Wicks, TrialScope Chief Strategy Officer, moderates a discussion on data and at CBI's conference in Miami. He's joined by Jo Anne-Marie Blyskal​, Teva; Danielle Leach, National Brain Tumor Society; and Mike Wenger, TrialScope VP of Patient Engagement.

    Poništi
  13. 23. sij
    Poništi
  14. 23. sij

    Thomas Wicks, Mike Wenger and Jaclyn Spedaliere are representing TrialScope at the CBI conference in Coral Gables. At 11:30, Thomas will moderate a panel discussion: "Elevate Patient Engagement through Improved Access of Clinical Information." Don't miss it!

    Poništi
  15. 21. sij

    is essential to quality healthcare. Low health literacy can be costly for patients, payers and providers - to the tune of $4.8 billion a year for payers, says a 2018 study. Health literacy can also have serious patient safety implications.

    Poništi
  16. 21. sij

    See how Merck KGaA made transparency a priority with its EMD Serono website. CISCRP collaborated to ensure that content was patient-friendly. TrialScope Engage technology completes the trifecta. Register now:

    Poništi
  17. 20. sij

    Penn State Cancer Institute researchers analyzed data from over 12 million patients with 46 different types of cancer between 2004 and 2015. They found that only 0.1% were enrolled in as their first course of therapy following diagnosis.

    Poništi
  18. 20. sij

    The degree of digital – of physicians, patients, institutions and payers – can really make the difference between an efficient integration and a missed opportunity, says one communications professional.

    Poništi
  19. 20. sij

    transparency still eludes the system in India, especially for the patient, says the president of the Indian Society for Clinical Research and advocacy groups.

    Poništi
  20. 20. sij

    Failure to report results on distorts evidence, breaches ethical obligations, and represents research waste. See how industry/non-industry, large/small sponsors fared in this comprehensive study.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·